Rep. Joe Neguse, D-Colo., vice chairman of the subcommittee, is calling for a hearing to probe federal enforcers' approach to evaluating pharmaceutical mergers.
The agency has challenged 67 pharmaceutical mergers worth over $900 billion since 1994, according to data compiled by the American Antitrust Institute for a September report.
"It would be one thing if the acquisitions resulted in deterring future anticompetitive conduct anddecreased drug prices for consumers.
The Covid-19 pandemic has called attention to existing concerns of rising drug prices and reduced innovation, Neguse wrote the committee leaders.
WATCH: Here's why some experts are calling for a breakup of Big Tech after the House antitrust report
Persons:
Joe Neguse, Jerrold Nadler, David Cicilline, Neguse, Rohit Chopra, Rebecca Kelly Slaughter, Chopra, Christine Wilson
Organizations:
Apple, Facebook, Google, Big Pharma, CNBC, Big Tech, Federal Trade, Democratic, American Antitrust Institute, Office, Allergan, Pfizer, Mylan, Republican, Federal Trade Commission, Merck, YouTube